Dispersome IP ApS: Financial statements 2026
CVR: 44931478
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
Dispersome IP ApS (CVR 44931478) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -1,423,180 and a net result of DKK -21,557,881. Equity in the 2026 report amounted to DKK -4,504,747.
- Gross Profit
- DKK -1,423,180
- Profit/Loss
- DKK -21,557,881
- Equity
- DKK -4,504,747
- Total Assets
- DKK 639,692
- Employees
- 0
Official annual report
Find more companies like Dispersome IP ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2026
As of September 7, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of Dispersome IP ApS.
As of September 7, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Dispersome IP ApS.
About Dispersome IP ApS
Dispersome IP ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Christoph Brücher. The board consists of Ole Sylvester-Hvid Wiborg (chair), Christoph Brücher, Korbinian Arthur Maria Löbmann and Márcio Milton Nunes Temtem. The company is owned by Zerion Pharma A/S and HOVIONE FARMACIÊNCIA, S.A.. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -1,423,180 and a net result of DKK -21,557,881. Equity in the 2026 report amounted to DKK -4,504,747.